Literature DB >> 12711653

Polyenylphosphatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring s-adenosylmethionine.

Semyon I Aleynik1, Charles S Lieber.   

Abstract

AIMS: Since the late stages of alcoholic liver injury are associated with decreased activity of methionine adenosyltransferase (MAT), we wondered whether this already occurs at the early stages and what is the mechanism involved.
METHODS: Sprague-Dawley rats (n = 32) were pair-fed ethanol (36% of energy) or isocaloric carbohydrates (control) in Lieber-DeCarli liquid diets, with or without polyenylphosphatidylcholine (PPC).
RESULTS: After 2 months, there was a striking depletion of S-adenosylmethionine (measured by high-performance liquid chromatography) from 68.2 +/- 5.1 to 36.2 +/- 3.4 nmol/g, associated with a reduction in hepatic reduced glutathione (GSH) from 4.95 +/- 0.20 to 4.09 +/- 0.08 micro mol/g, and an increase from 0.24 +/- 0.02 to 0.47 +/- 0.07 nmol/g of 4-hydroxynonenal (4-HNE), a reliable marker of lipid peroxidation. Hepatic S-adenosylmethionine (SAMe) correlated positively with GSH (r = 0.5916) and negatively with 4-HNE (r = -0.6375). Feeding PPC corrected all values and MAT activity did not differ significantly between groups.
CONCLUSIONS: SAMe depletion occurs already after 8 weeks of alcohol feeding and is fully corrected by PPC, in parallel with the prevention by PPC of the alcohol-induced oxidative stress. Since phosphatidylcholines (PCs) are produced in the liver via methylation of phosphatidylethanolamine by SAMe, it is likely that PPC, by providing PCs, decreases the utilization of SAMe and thereby contributes to its restoration, with replenishment of GSH and correction of the alcohol-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711653     DOI: 10.1093/alcalc/agg066

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  9 in total

Review 1.  Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?

Authors:  Akshata Moghe; Swati Joshi-Barve; Smita Ghare; Leila Gobejishvili; Irina Kirpich; Craig J McClain; Shirish Barve
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

Authors:  Elisabetta Mormone; Joseph George; Natalia Nieto
Journal:  Chem Biol Interact       Date:  2011-07-22       Impact factor: 5.192

Review 3.  Vitamin-dependent methionine metabolism and alcoholic liver disease.

Authors:  Charles H Halsted; Valentina Medici
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 4.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

Review 5.  The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway.

Authors:  Rima Obeid
Journal:  Nutrients       Date:  2013-09-09       Impact factor: 5.717

6.  Aberrant hepatic methionine metabolism and gene methylation in the pathogenesis and treatment of alcoholic steatohepatitis.

Authors:  Charles H Halsted; Valentina Medici
Journal:  Int J Hepatol       Date:  2011-09-06

7.  Phosphatidylcholine induces apoptosis of 3T3-L1 adipocytes.

Authors:  Hailan Li; Jong-Hyuk Lee; Su Yeon Kim; Hye-Young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Yoosik Yoon; Ji Hoon Jeong; Dong-Seok Kim
Journal:  J Biomed Sci       Date:  2011-12-07       Impact factor: 8.410

8.  Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats.

Authors:  Wei Ling Lau; Mahyar Khazaeli; Javad Savoj; Kasim Manekia; Maria Bangash; Roshni G Thakurta; Anhthu Dang; Nosratola D Vaziri; Bhupinder Singh
Journal:  Pharmacol Res Perspect       Date:  2018-02-19

9.  Mood disorders and complementary and alternative medicine: a literature review.

Authors:  Naseem Akhtar Qureshi; Abdullah Mohammed Al-Bedah
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-14       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.